eFFECTOR Therapeutics, Inc. (EFTR)
(Real Time Quote from BATS)
$1.35 USD
-0.03 (-2.17%)
Updated Jun 7, 2024 11:36 AM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for eFFECTOR Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -35.81 | -22.67 | 15.80 | 0.00 | NA |
Depreciation/Amortization & Depletion | -0.36 | 0.02 | 0.02 | 0.00 | NA |
Net Change from Assets/Liabilities | 1.69 | 2.68 | -0.24 | 0.00 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 4.94 | -5.93 | -40.47 | 0.00 | NA |
Net Cash From Operating Activities | -29.55 | -25.90 | -24.89 | 0.00 | NA |
Property & Equipment | -0.10 | -0.19 | 0.57 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 14.58 | -17.67 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 14.48 | -17.86 | 0.57 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 21.23 | 2.80 | 52.91 | 0.03 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 5.90 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.06 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | -0.04 | 0.00 | -0.07 | NA |
Net Cash from Financing Activities | 21.23 | 2.77 | 58.81 | 0.01 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 6.17 | -40.99 | 34.49 | 0.01 | NA |
Cash at Beginning of Period | 8.71 | 49.70 | 15.22 | 0.00 | NA |
Cash at End of Period | 14.88 | 8.71 | 49.70 | 0.01 | NA |
Diluted Net EPS | -16.37 | -13.75 | 11.00 | -0.01 | NA |
Fiscal Year End for eFFECTOR Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.83 | -35.81 | -26.68 | -18.38 | -10.01 |
Depreciation/Amortization & Depletion | -0.03 | -0.36 | -0.29 | -0.14 | -0.09 |
Net Change from Assets/Liabilities | 0.48 | 1.69 | -0.74 | -0.22 | 1.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.11 | 4.94 | 3.73 | 2.51 | 1.26 |
Net Cash From Operating Activities | -7.28 | -29.55 | -23.98 | -16.23 | -7.64 |
Property & Equipment | 0.00 | -0.10 | -0.04 | -0.04 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -6.32 | 14.58 | 5.58 | 7.49 | 9.04 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -6.32 | 14.48 | 5.54 | 7.45 | 9.03 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 14.79 | 21.23 | 15.12 | 14.78 | 0.21 |
Issuance (Repayment) of Debt | -0.56 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 14.23 | 21.23 | 15.12 | 14.78 | 0.21 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 0.63 | 6.17 | -3.32 | 6.01 | 1.60 |
Cash at Beginning of Period | 14.88 | 8.71 | 8.71 | 8.71 | 8.71 |
Cash at End of Period | 15.51 | 14.88 | 5.39 | 14.71 | 10.31 |
Diluted Net EPS | -2.16 | -2.87 | -3.25 | -4.25 | -6.00 |